ABT a slow moving low beta medical stock

ABT is Abbott Labs, a well-established medical technology company has had good earnings

twice this year. In the first episode, the price trended down then recovered in a retracement.

I have anchored a long-term mean VWAP and its standard deviations as a means to assess

areas of dynamic support and resistance. One week ago, the price crossed the mean VWAP in

its uptrend. I see this as a good place for a long trade over a month or more. For a stop loss

I will place the stop below the mean VWAP also confluent with two horizontal support lines

as well as the rising support trendline and the POC line of the volume profile

Targets are the first and second standard deviations at about $105 and $110. I will make an

optimal entry from a pivot low on a timeframe of 30-90 minutes.

As the anticipated ROI is relatively small although with reasonable risk, my approach is

a call option for mid-September with a strike in the range of $100-104. I expect this to

yield 25% or more monthly until signs of a pullback or reversal. While the general market

has heightened volatility and controlled chaos, I see adding some trades of slow-moving

low beta stocks to be proper risk management.